Worldwide, the number of potential pathogens is very large, while the resources for disease research and development (R&D) is limited. To ensure efforts under WHO’s R&D Blueprint are focused and productive, a list of diseases and pathogens are prioritized for R&D in public health emergency contexts.
In this video, we went searching for evidence that the public health innovations and scientific progress this country is famous for are still alive and well. Our journey to find lifesaving American initiatives introduced us to some interesting people: from a virus hunter in the bat caves in Thailand to a group of South Korean epidemiologists who just might have predicted this pandemic.
New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19.
